There is a promising new drug for the rare disease mastocytosis, which is associated with skin lesions, among other things. Researchers at the University of Basel have now been able to use artificial ...
In 2005, the governments of Bangladesh, India and Nepal, in partnership with the WHO, started the Kala-azar Elimination Programme (KEP) to reduce the incidence of visceral leishmaniasis to below 1 new ...
Two new studies from investigators at Mass General Brigham challenge a decades-old assumption that the thymus, an organ best known for its role in establishing immune function in childhood, becomes ...
The recent introduction of High-Efficacy Therapies (HETs) in clinical practice has drastically reduced the frequency of acute inflammatory episodes and relapses, in patients with Multiple Sclerosis ...
bNephrology Division and Kidney Research Institute, University of Washington School of Medicine, Seattle, WA, USA cDepartment of Medicine, University of Washington School of Medicine, Seattle, WA, USA ...
The ubiquitin–proteasome system (UPS) is a central mechanism for maintaining cellular homeostasis through the regulated turnover of proteins (Pickart, 2001; Hershko and Ciechanover, 1998).
Federal health officials on Monday laid out a proposal to spur development of customized treatments for patients with hard-to-treat diseases, including for rare genetic conditions that the ...
Copyright 2026 The Associated Press. All Rights Reserved. Copyright 2026 The Associated Press. All Rights Reserved. President Donald Trump listens as Dr. Marty Makary ...
FDA Rare Diseases FILE - President Donald Trump listens as Dr. Marty Makary, commissioner of the Food and Drug Administration, speaks in the Roosevelt Room of the White House, Monday, Sept. 22, 2025, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results